Literature DB >> 3449301

Disease-modifying drugs for rheumatoid arthritis. Asset or liability?

H A Bird.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3449301     DOI： 10.1007/BF02330584

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  15 in total

1.  Long-term chrysotherapy in rheumatoid arthritis.

Authors:  R Srinivasan; B L Miller; H E Paulus
Journal:  Arthritis Rheum       Date:  1979-02

2.  Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?

Authors:  R Madhok; H A Capell; R Waring
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

3.  Intensive immunosuppression in intractable rheumatoid arthritis.

Authors:  A I Binder; A So; B M Ansell; A M Denman
Journal:  Br J Rheumatol       Date:  1986-11

4.  Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritic patients.

Authors:  R Ayesh; S C Mitchell; R H Waring; R H Withrington; M H Seifert; R L Smith
Journal:  Br J Rheumatol       Date:  1987-06

5.  Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.

Authors:  R F Willkens; H J Williams; J R Ward; M J Egger; J C Reading; P J Clements; E S Cathcart; C O Samuelson; M A Solsky; S B Kaplan
Journal:  Arthritis Rheum       Date:  1984-04

6.  HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P Perrier; C Raffoux; P Thomas; J N Tamisier; M Busson; A Gaucher; F Streiff
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

7.  Gold-induced aplastic anemia.

Authors:  L M Williame; R Joos; F Proot; C Immesoete
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

8.  Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity.

Authors:  P A Leonard; D O Clegg; C C Carson; G W Cannon; M J Egger; J R Ward
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

9.  Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.

Authors:  D J McCarty; G F Carrera
Journal:  JAMA       Date:  1982-10-08       Impact factor: 56.272

10.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.